Quantcast

Research on China’s FISH Probe (Fluorescent in Situ Hybridization Probe) Industry, 2013-2017

December 5, 2013

Reportbuyer.com just published a new market research report: Research on China’s FISH Probe (Fluorescent in Situ Hybridization Probe) Industry, 2013-2017.

London (PRWEB) December 05, 2013

According to Huidian’s market research, the output value of China’s FISH probe market in 2012 was about CNY 20 million to CNY 30 million; with the improvement of people’s living standard and medical conditions in the future, FISH probe products will be more and more used in medical diagnosis.

The main brands of China’s FISH probe industry are GP, Abbott, LBP, Zhongsheng Damaidi, BioChina and Zhejiang Orient Gene. In 2012, the FISH probes of GP and Abbott occupied the monopoly position in domestic market, and the market share was about 51% and 32 % respectively, and the market share of LBP was about 13%.

At present, the annual sales of China’s clinical diagnostic reagent market has developed to CNY 3 billion to CNY 4 billion, of which, clinical biochemistry accounted for 30%, the immune products accounted for 25%, and the blood products and urine analysis products ranged from 8% to 10% and 3% to 5% respectively, the microbial products accounted for 2% to 3%. According to the estimate of experts, the annual growth rate of domestic clinical diagnostic market will reach 15% to 20% in the next five years.

Huidian Research predicts that the growth rate of FISH probe market will be not lower than 15% in the future. Therefore, it is estimated that the output value in this market will be about CNY 32 million in 2013, and this number will reach CNY 56 million by 2017.

1. Overview of China’s FISH Probe Products

1.1 Product Overview

1.1.1 Introduction

1.1.2 Classification

1.1.3 Advantages

1.2 FISH Technology and Similarities and Differences Compares With Other Technologies

1.3 Application Areas

2. Development Environment of China’s FISH Probe Industry

2.1 Economic Environment

2.1.1 Development of Macro-economy

2.1.2 Income Growth

2.1.3 Investment in the Fixed Assets

2.1.4 Changes of RMB Exchange Rate

2.2 Policy Environment

2.3 Social Environment

2.3.1 Population Size

2.3.2 Age Structure

2.3.3 Sex Structure

3. Development of Global FISH Probe Industry

4. Status Quo of China’s FISH Probe Industry

4.1 Status Quo

4.2 Competitive Structure

4.3 Development Cycle

5. Economic Operation of China’s FISH Probe Industry, 2009 – June, 2012

5.1 Production and Sales

5.2 Scale

5.3 Profitability

5.4 Operation and Development Ability

5.5 Debt Paying Ability

6. Analysis and Forecast of Market Demand and Supply in China’s FISH Probe Industry

6.1 Supply Analysis and Forecast

6.2 Product Applications

6.2.1 Application in Antenatal and Abortion Diagnosis

6.2.2 Application in Breast Cancer

6.2.3 Application in Bladder Cancer

6.2.4 Application in Cervical Cancer

6.2.5 Application in Lung Cancer

6.2.6 Application Blood Disease

6.2.7 Application in Other Tumors

6.3 Demand Analysis and Forecast

7. Technology Development of China’s FISH Probe Industry

7.1 Technology Development History

7.1.1 Development of FISH Technical Detection Locus Number and Detection Target

7.1.2 Quantitative Analysis Phase

7.1.3 Development of Detection Field

7.2 Existing Problems of FISH Technology

8. Key Enterprises in China’s FISH Probe Industry

8.1 Abbott

8.1.1 Company Profile

8.1.2 Products Introduction

8.1.3 Main Clients

8.1.4 State of Operation

8.2 LBP Pharmaceutical Science and Technology Co., Ltd.

8.2.1 Company Profile

8.2.2 Main Clients

8.2.3 Scientific Research Strength

8.2.4 Production Capacity

8.2.5 State of Operation

8.3 BioChina Group

8.3.1 Company Profile

8.3.2 Main Clients

8.3.3 State of Operation

8.4 Beijing Zhongsheng Damaidi Molecular Diagnosis Technology Co., Ltd. (A Subsidiary of BioSino Bio-technology and Science Inc.)

8.4.1 Company Profile

8.4.2 Main Clients

8.4.3 State of Operation

8.5 Zhejiang Orient Gene Biotech Co., Ltd.

8.5.1 Company Profile

8.5.2 Introduction of Main Products

8.5.3 State of Operation

9. Challenges and Opportunities of China’s FISH Probe Industry

9.1 Challenges

9.1.1 Policy Challenge

9.1.2 Market Challenge

9.1.3 Technology Challenge

9.1.4 Management Challenge

9.2 Development Opportunity

10. Development and Strategy Analysis of China’s FISH Probe Industry

10.1 Development Trend

10.2 Development Direction

10.3 Strategy

10.3.1 Marketing Strategy

10.3.2 Scientific Research Strategy

10.3.3 Operating Strategy

Companies Mentioned

Abbott

LBP Pharmaceutical Science and Technology Co., Ltd.

BioChina Group

Beijing Zhongsheng Damaidi Molecular Diagnosis Technology Co., Ltd. (A Subsidiary of BioSino Bio-technology and Science Inc.)

Zhejiang Orient Gene Biotech Co., Ltd.

Read the full report:

Research on China’s FISH Probe (Fluorescent in Situ Hybridization Probe) Industry, 2013-2017

http://www.reportbuyer.com/pharma_healthcare/diagnostics/research_chinas_fish_probe_fluorescent_situ_hybridization_probe_industry_2013_2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Diagnostics

For more information:

Sarah Smith

Research Advisor at Reportbuyer.com

Email: query@reportbuyer.com

Tel: +44 208 816 85 48

Website: http://www.reportbuyer.com/

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/12/prweb11396871.htm


Source: prweb



comments powered by Disqus